Immuno-histopathologic Evaluation of Mineralized Plasmatic Matrix in the Management of Horizontal Ridge Defects in a Canine Model (a Split-mouth Comparative Study)

Overview

Journal Odontology

Specialty Dentistry

Date 2022 Jan 6

PMID 34988770

Citations 3

Authors

Souzy Kamal Anwar

Hend Mohamed Abdel Hamid

Affiliations

Soon will be listed here.

Abstract

Our research aimed to investigate the effect of combining biphasic calcium phosphate (BCP) alloplast with mineralized plasmatic matrix (MPM) as compared with platelet-rich fibrin (PRF) on the quality and quantity of bone formation and maturation at surgically created horizontal critical-sized ridge defects (HRDs) in a canine model. We used a split-mouth design using the third and fourth mandibular premolars of the mongrel dogs. Twelve defects on the left side (experimental group, I) were managed with MPM composite mixed with BCP alloplast, MPM compact layer. On the right side (control group, II), another 12 defects were managed with PRF mixed with BCP alloplast, followed by the application of PRF compact strips. Finally, both were covered by a collagen membrane. Dogs were euthanized at 4, 8, and 12 weeks, and the studied defects were processed to evaluate treatment outcome, including mean percentage of bone surface area, collagen percentage, and osteopontin (OPN) immunoreaction. Our results revealed that the mean percentage of bone surface area was significantly increased in the experimental group treated with MPM at all time intervals as compared with the PRF group. Decreased collagen percentage and increased OPN immunoreactivity showed significant results in the MPM group as compared with PRF at 4 and 8 weeks postoperatively, respectively. In conclusion, MPM accelerates the formation of superior new bone quality when used in the treatment of HRDs.

Citing Articles

Histomorphometric and immunohistochemical assessment of treated dentin matrix delivered by platelet-rich fibrin for socket preservation in rabbit model.

Sedek E, Khalil N, Abdul-Monem M BMC Oral Health. 2025; 25(1):225.

PMID: 39939950 PMC: 11823050. DOI: 10.1186/s12903-025-05569-3.

Navigating the combinations of platelet-rich fibrin with biomaterials used in maxillofacial surgery.

Ievina L, Dubnika A Front Bioeng Biotechnol. 2024; 12:1465019.

PMID: 39434715 PMC: 11491360. DOI: 10.3389/fbioe.2024.1465019.

Determination of critical-sized defect of mandible in a rabbit model: Micro-computed tomography, and histological evaluation.

Wang Y, Zhang X, Mei S, Li Y, Khan A, Guan S Heliyon. 2023; 9(7):e18047.

PMID: 37539284 PMC: 10393617. DOI: 10.1016/j.heliyon.2023.e18047.

Standardization of Animal Models and Techniques for Platelet-Rich Fibrin Production: A Narrative Review and Guideline.

Mourao C, Lowenstein A, Mello-Machado R, Ghanaati S, Pinto N, Kawase T Bioengineering (Basel). 2023; 10(4).

PMID: 37106669 PMC: 10135737. DOI: 10.3390/bioengineering10040482.

References

Belser U, Schmid B, Higginbottom F, Buser D . Outcome analysis of implant restorations located in the anterior maxilla: a review of the recent literature. Int J Oral Maxillofac Implants. 2005; 19 Suppl:30-42. View

Grunder U, Gracis S, Capelli M . Influence of the 3-D bone-to-implant relationship on esthetics. Int J Periodontics Restorative Dent. 2005; 25(2):113-9. View

Bernstein S, Cooke J, Fotek P, Wang H . Vertical bone augmentation: where are we now?. Implant Dent. 2006; 15(3):219-28. DOI: 10.1097/01.id.0000226824.39526.71. View

Barradas A, Yuan H, van Blitterswijk C, Habibovic P . Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms. Eur Cell Mater. 2011; 21:407-29. DOI: 10.22203/ecm.v021a31. View

N P, Abhilash A, Saquib S, Malgaonkar N, Kudyar N, Gupta A . Clinical Efficacy of Subgingivally Delivered 1.2 mg Simvastatin in the Treatment of Patients with Aggressive Periodontitis: A Randomized Controlled Clinical Trial. Int J Periodontics Restorative Dent. 2017; 37(2):e135-e141. DOI: 10.11607/prd.2936. View

Cochran D, Cobb C, Bashutski J, Chun Y, Lin Z, Mandelaris G . Emerging regenerative approaches for periodontal reconstruction: a consensus report from the AAP Regeneration Workshop. J Periodontol. 2014; 86(2 Suppl):S153-6. PMC: 4469971. DOI: 10.1902/jop.2015.140381. View

Clark R . Fibrin and wound healing. Ann N Y Acad Sci. 2001; 936:355-67. DOI: 10.1111/j.1749-6632.2001.tb03522.x. View

Trombelli L, Farina R . Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. J Clin Periodontol. 2008; 35(8 Suppl):117-35. DOI: 10.1111/j.1600-051X.2008.01265.x. View

Marx R, Carlson E, Eichstaedt R, Schimmele S, Strauss J, Georgeff K . Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 85(6):638-46. DOI: 10.1016/s1079-2104(98)90029-4. View

10.

Plachokova A, Nikolidakis D, Mulder J, Jansen J, Creugers N . Effect of platelet-rich plasma on bone regeneration in dentistry: a systematic review. Clin Oral Implants Res. 2008; 19(6):539-45. DOI: 10.1111/j.1600-0501.2008.01525.x. View

11.

Choukroun J, Diss A, Simonpieri A, Girard M, Schoeffler C, Dohan S . Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101(3):e56-60. DOI: 10.1016/j.tripleo.2005.07.011. View

12.

Choukroun J, Diss A, Simonpieri A, Girard M, Schoeffler C, Dohan S . Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101(3):299-303. DOI: 10.1016/j.tripleo.2005.07.012. View

13.

Amine K, Gharibi A, Hsaine A, Kissa J . Effect of Bone Regeneration with Mineralized Plasmatic Matrix for Implant Placement in Aesthetic Zone. Case Rep Dent. 2017; 2017:2639564. PMC: 5387826. DOI: 10.1155/2017/2639564. View

14.

Sghaireen M, Ganji K, Alam M, Rahman S, Billah S . Mineralized Plasmatic Matrix in Ridge Preservation: A Randomized Controlled Clinical Trial. Int J Periodontics Restorative Dent. 2021; 41(3):e103-e112. DOI: 10.11607/prd.4972. View

15.

Ellapakurthi P, Reddy G . The effectiveness of mineralized plasmatic matrix in the closure of alveolar clefts with volumetric assessment. Regen Med Res. 2021; 9:1. PMC: 8274394. DOI: 10.1051/rmr/210004. View

16.

Lund S, Giachelli C, Scatena M . The role of osteopontin in inflammatory processes. J Cell Commun Signal. 2009; 3(3-4):311-22. PMC: 2778587. DOI: 10.1007/s12079-009-0068-0. View

17.

Rakmanee T, Griffiths G, Auplish G, Darbar U, Petrie A, Olsen I . Radiographic outcomes following treatment of intrabony defect with guided tissue regeneration in aggressive periodontitis. Clin Oral Investig. 2015; 20(6):1227-35. DOI: 10.1007/s00784-015-1609-y. View

18.

Machtei E, Cho M, Dunford R, Norderyd J, Zambon J, Genco R . Clinical, microbiological, and histological factors which influence the success of regenerative periodontal therapy. J Periodontol. 1994; 65(2):154-61. DOI: 10.1902/jop.1994.65.2.154. View

19.

Yilmaz D, Dogan N, Ozkan A, Sencimen M, Ora B, Mutlu I . Effect of platelet rich fibrin and beta tricalcium phosphate on bone healing. A histological study in pigs. Acta Cir Bras. 2014; 29(1):59-65. DOI: 10.1590/S0102-86502014000100009. View

20.

Bolukbasi N, Yeniyol S, Tekkesin M, Altunatmaz K . The use of platelet-rich fibrin in combination with biphasic calcium phosphate in the treatment of bone defects: a histologic and histomorphometric study. Curr Ther Res Clin Exp. 2014; 75:15-21. PMC: 3898181. DOI: 10.1016/j.curtheres.2013.05.002. View